Whether it will become benign prostatic hyperplasia prostate cancer?

My benign prostatic hyperplasia in patients with prostate cancer at the same time in the ratio of around 5%, the proportion of lower Europe and the United States, and other countries, but higher than in the Middle East and the Israelis.
For a long time there were two different views to review the relationship between the two, a view in some benign prostatic hyperplasia and adenoma of the cancerous gland precancerous dysplasia in the state, and some can be seen from the development of precancerous lesions a cancer, but how long the incubation period is still uncertain. Another view was that benign prostatic hyperplasia and prostate cancer and can be stored in a glands are two different entities, each have their own laws governing the development, can be endocrine effects. BPH occurs in prostate transitional zone, which is around the urethra by stimulating the surrounding matrix nodular hyperplasia of the glands and development; and prostate cancer occurred in peripheral areas coated glands, although the two coexist in a glands, but in different parts of the prostate, both in the event there is no relationship.
Most scientists agree that the current benign prostatic hyperplasia and prostate cancer are older men common diseases, they can coexist in a gland, the endocrine a similar study in a similar environment or under the influence of growth, but occurred in different parts of the prostate, although simultaneously, but unrelated, benign prostatic hyperplasia malignant transformation of the argument was not confirmed.